We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

New Cellular Reporter Technologies using X-MAN™ Cell Models Poster

SEARCH POSTERS

Abstract

Paul Morrill1, Chris Torrance1, Christine Schofield1, Holly Astley1, Sue Rigby1, Tom Henley1, Claire Mahoney1, Paul Gonzales2, Bernardo Chavira2, Mei Cong3, Danette Daniels3, Hélène Benink3, Nancy Murphy3, Jeff Kelly3
1Horizon Discovery Ltd, Cambridge, UK, 2TGen Drug Development, Scottsdale, Arizona, USA, 3Promega Corporation, Madison, Wisconsin, USA

X‐MAN™ (gene‐X Mutant And Normal) cell lines provide genetically defined, patient‐relevant, predictive in vitro models of genetic disease. We are further extending their application within targeted drug discovery with the development of new reporter disease models using our GENESIS™ gene engineering technology (Figure 1). These models combine X‐MAN™ cell lines with the endogenous gene reporting capabilities in the form of NanoLuc™ luciferase and HaloTag® reporter technologies.

Document Icon Download the poster PDF (1213kb)

  • Part# PS142
  • Printed in USA.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.